Table 3.
Expression of GSK-3β and phospho-GSK-3β localized to the cytoplasm in PAs and LSTs
| GSK-3β
|
Phospho-GSK-3β
|
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | 0 | 1+ | 2+ | 3+ | p | n | 0 | 1+ | 2+ | 3+ | p | |
| LST | 50 | 12 | 26 | 8 | 4 | 0.101a | 50 | 9 | 14 | 19 | 8 | 0.001a |
| LGIN | 29 | 8 | 16 | 4 | 1 | 0.019b | 29 | 7 | 10 | 10 | 2 | 0.036b |
| HGIN | 21 | 4 | 10 | 4 | 3 | 0.432c | 21 | 2 | 4 | 9 | 6 | 0.007c |
| PA | 54 | 26 | 15 | 7 | 6 | 54 | 24 | 17 | 10 | 3 | ||
| LGIN | 37 | 22 | 11 | 3 | 1 | 37 | 18 | 11 | 6 | 2 | ||
| HGIN | 17 | 4 | 4 | 4 | 5 | 17 | 6 | 6 | 4 | 1 | ||
a
LSTs vs PAs.
b
LSTs-LGIN vs PAs-LGIN.
c
LSTs-HGIN vs PAs-HGIN.
Correlation with grade of intraepithelial neoplasia. LGIN, low-grade intraepithelial neoplasia; HGIN, high-grade intraepithelial neoplasia.